发明授权
- 专利标题： Nuclear receptor binding agents
- 专利标题（中）： 核受体结合剂
-
申请号： US11785251申请日： 2007-04-16
-
公开(公告)号： US08158828B2公开(公告)日： 2012-04-17
- 发明人: James T. Dalton , Christina Barrett , Yali He , Seoung-Soo Hong , Duane D. Miller , Michael L. Mohler , Ramesh Narayanan , Zhongzhi Wu
- 申请人： James T. Dalton , Christina Barrett , Yali He , Seoung-Soo Hong , Duane D. Miller , Michael L. Mohler , Ramesh Narayanan , Zhongzhi Wu
- 申请人地址： US TN Memphis
- 专利权人： GTx, Inc.
- 当前专利权人： GTx, Inc.
- 当前专利权人地址： US TN Memphis
- 代理机构： Pearl Cohen Zedek Latzer, LLP
- 代理商 Mark S. Cohen
- 主分类号： C07C233/65
- IPC分类号： C07C233/65 ; A61K31/165
摘要：
The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
公开/授权文献
- US20070265296A1 Nuclear receptor binding agents 公开/授权日：2007-11-15
信息查询
